EX-23.1 3 d851681dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Coya Therapeutics, Inc. of our report dated March 19, 2024 relating to the financial statements appearing in Coya Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2023.

We also consent to the reference to us under the caption “Experts” in the Prospectus.

/s/ Weaver and Tidwell, L.L.P

Austin, Texas

June 14, 2024